These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells. Xie M; Tian J; Luo Y; Wei L; Lin S; Tang S Mol Vis; 2014; 20():1411-21. PubMed ID: 25352747 [TBL] [Abstract][Full Text] [Related]
5. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy. Chen J; Sun Y; Chen L; Zhou Y Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway. Xian Y; Wang X; Yu Y; Chen X Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238 [TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid ameliorates non-proliferative diabetic retinopathy via alleviating retinal inflammation through targeting TNFR1 in retinal endothelial cells. Ouyang H; Xie Y; Du A; Dong S; Zhou S; Lu B; Wang Z; Ji L Int Immunopharmacol; 2024 Nov; 141():112929. PubMed ID: 39153307 [TBL] [Abstract][Full Text] [Related]
8. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment. Wang XL; Xian Y; Chen XL Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219 [TBL] [Abstract][Full Text] [Related]
9. Transthyretin represses neovascularization in diabetic retinopathy. Shao J; Yao Y Mol Vis; 2016; 22():1188-1197. PubMed ID: 27746673 [TBL] [Abstract][Full Text] [Related]
10. miR-152/LIN28B axis modulates high-glucose-induced angiogenesis in human retinal endothelial cells via VEGF signaling. Fu X; Ou B J Cell Biochem; 2020 Feb; 121(2):954-962. PubMed ID: 31609010 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902 [TBL] [Abstract][Full Text] [Related]
12. [Wogonoside alleviates high glucose-induced dysfunction of retinal microvascular endothelial cells and diabetic retinopathy in rats by up-regulating SIRT1]. Shao X; Yu J; Ni W Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):463-472. PubMed ID: 35527482 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis. Ke N; Pi LH; Liu Q; Chen L Biochem Biophys Res Commun; 2019 Jun; 514(2):503-509. PubMed ID: 31056258 [TBL] [Abstract][Full Text] [Related]
14. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α. Han N; Xu H; Yu N; Wu Y; Yu L Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells. Xie M; Hu A; Luo Y; Sun W; Hu X; Tang S Mol Vis; 2014; 20():921-8. PubMed ID: 24991184 [TBL] [Abstract][Full Text] [Related]
16. The Effects of the CXCR4 Antagonist, AMD3465, on Human Retinal Vascular Endothelial Cells (hRVECs) in a High Glucose Model of Diabetic Retinopathy. Wu D; Jin L; Xu H Med Sci Monit; 2019 Sep; 25():6946-6954. PubMed ID: 31860633 [TBL] [Abstract][Full Text] [Related]
17. Chemerin promotes microangiopathy in diabetic retinopathy via activation of ChemR23 in rat primary microvascular endothelial cells. Jun L; Lin-Lin S; Hui S Mol Vis; 2021; 27():575-587. PubMed ID: 34531648 [TBL] [Abstract][Full Text] [Related]
18. Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy. Yuan Y; Zhu A; Zeng L; Wang X; Zhang Y; Long X; Wu J; Ye M; He J; Tan W BMC Ophthalmol; 2024 Jun; 24(1):267. PubMed ID: 38907191 [TBL] [Abstract][Full Text] [Related]
19. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180 [TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis. Duan J; Du C; Shi Y; Liu D; Ma J Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]